Jury echoes judge in Medtronic/Guidant stent case
This article was originally published in Clinica
A Delaware jury has issued a verdict in Guidant's favour in a lawsuit against Medtronic over patents covering stent technology. The jury found that Medtronic stents, including the cobalt alloy Driver stent that forms the platform for its development-stage drug-eluting device, infringed Guidant's Lau patents. It also ruled that the Lau patents were valid.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.